Pharmaceutical manufacturing

Commuters wearing face masks to protect against the spread of the new coronavirus walk through a subway station in Beijing, Thursday, July 9, 2020. (AP Photo/Mark Schiefelbein)
1010 WINS Newsroom
July 08, 2020 - 11:24 pm
BEIJING — China says it has nine new confirmed coronavirus cases, all of them brought from outside the country, and no new deaths. Thursday’s report buttresses growing signs the virus has been essentially contained inside the nation in which it first appeared late last year. The near elimination of...
Read More
Democratic presidential candidate, former Vice President Joe Biden puts on a face mask to protect against the spread of the new coronavirus as he departs after speaking at Alexis Dupont High School in Wilmington, Del., Tuesday, June 30, 2020. (AP Photo/Patrick Semansky)
1010 WINS Newsroom
July 07, 2020 - 3:03 pm
WASHINGTON (AP) — Joe Biden is promising to shift production of medical equipment and other key pandemic-fighting products “back to U.S. soil," creating jobs and bolstering a domestic supply chain he says has been exposed as inadequate and vulnerable by the coronavirus outbreak. The presumptive...
Read More
FILE -In this Monday, Sept. 3, 2019 file photo, the logo is pictured of the pharmaceutical giant Servier Laboratoires in Suresnes, outside Paris. French pharmaceutical company Servier Laboratories is facing millions of euros in potential fines after a massive trial around a diabetes drug used as a diet pill. The popular drug, called Mediator, became one of France’s biggest modern health scandals. The trial is wrapping up Monday, July 6, 2020 after more than six months of exceptional proceedings targeting Servier and France’s medicines watchdog. (AP Photo/Michel Euler, File)
1010 WINS Newsroom
July 06, 2020 - 6:55 am
PARIS (AP) — Accused of favoring profits over patients’ lives, French pharmaceutical company Servier Laboratories is facing millions of euros in potential fines and damages after a huge trial involving 6,500 plaintiffs who say the company allowed a diabetes drug to be widely and irresponsibly...
Read More
A Venezuelan migrant girl, wearing a protective face mask with a graphic version of the Virgin of Guadalupe, waits for a bus to travel to the border, after breaking camp in Bogota, Colombia, Thursday, July 2, 2020. Facing no work due to the COVID-19-related economic shutdown, hundreds of Venezuelan migrants are returning to their country. (AP Photo/Fernando Vergara)
1010 WINS Newsroom
July 02, 2020 - 10:56 pm
SEOUL, South Korea -- South Korea has reported 63 newly confirmed cases of COVID-19 as health authorities scramble to mobilize public health tools to the southwestern city of Gwangju, where more than 50 people were found sickened over the past week. The figures announced by the Korea Centers for...
Read More
A woman wearing a mask passes a sign for Wall Street, Tuesday, June 30, 2020, during the coronavirus pandemic. (AP Photo/Mark Lennihan)
1010 WINS Newsroom
July 01, 2020 - 11:18 pm
Asian stock markets followed Wall Street higher Thursday as hopes for development of a coronavirus vaccine competed with concern about rising U.S. infections. Benchmarks in Shanghai, Tokyo, Hong Kong and Australia all advanced. Investors were encouraged after Pfizer and BioNtech announced...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
1010 WINS Newsroom
July 01, 2020 - 3:33 pm
LONDON (AP) — Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19. The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir available to...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
1010 WINS Newsroom
June 29, 2020 - 11:54 am
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for...
Read More
A Koran War veteran walks through a sterilizer as a precaution against the new coronavirus while he arrives to attend a ceremony to mark the 70th anniversary of the outbreak of the Korean War in Cheorwon, near the border with North Korea, South Korea, Thursday, June 25, 2020. (AP Photo/Ahn Young-joon)
1010 WINS Newsroom
June 27, 2020 - 10:53 pm
SEOUL, South Korea — South Korea has confirmed 62 additional cases of the coronavirus over a 24-hour period as the Asian country continues to face new clusters of infections amid eased social distancing rules. The additional cases reported Sunday took the country’s total to 12,715, with 282 deaths...
Read More
Senegalese students learn about health and the coronavirus during an English lesson as they returned to classes on the first day back after more than three months away, at the Sacre Coeur college in Dakar, Senegal Thursday, June 25, 2020. (AP Photo/Sylvain Cherkaoui)
1010 WINS Newsroom
June 25, 2020 - 3:06 pm
JOHANNESBURG (AP) — Governments around the world should “remove all obstacles” to swift and equitable distribution of any successful COVID-19 vaccine, including by making all intellectual property and technologies immediately available, African countries said Thursday. The call from the African...
Read More
FILE - In this, Feb. 24, 2019, file photo, containers of Roundup are displayed at a store in San Francisco. German pharmaceutical company Bayer announced Wednesday, June 24, 2020, it’s paying up to $10.9 billion to settle a lawsuit over subsidiary Monsanto’s weedkiller Roundup, which has faced numerous lawsuits over claims it causes cancer. (AP Photo/Haven Daley, File)
1010 WINS Newsroom
June 24, 2020 - 5:07 pm
BERLIN (AP) — Bayer said Wednesday that it will pay up to $10.9 billion to settle litigation over the weedkiller Roundup, which has faced thousands of lawsuits over claims it causes cancer. Bayer said it was also paying up $1.22 billion to settle two additional areas of intense litigation, one...
Read More

Pages